Massachusetts General Hospital Researchers and Prevencio Announce the Power of Artificial Intelligence HART® Platform for Medical Diagnostic Test Development financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
The copper chelator trientine was well tolerated and lowered NT-proBNP levels in patients with heart failure and reduced ejection fraction in a phase 2 study.
Revisiting reasons for patient refusal or physician choice not to prescribe oral anticoagulation could improve use of anticoagulants in patients with atrial fibrillation at increased risk, researchers reported.The results of the Benchmarking an Oral Anticoagulant Treatment Rate in Patients with Nonvalvular Atrial Fibrillation (BOAT-AF) study were published in JAMA Network Open.
MedAlliance Leads US Sirolimus DEB Race: First US Patient Enrolled into SELUTION SLR Coronary Sirolimus DEB Study dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The first US patient has been enrolled at MedStar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to support FDA.